The EFMC wishes you a successful New Year!
News from the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (UK)
BMCS invites registrations and poster submissions for the 3rd New Perspectives in DMPK: The Impact of Drug Design and announces:
- the 2015 Malcom Campbell Memorial Prize
- the Royal Society of Chemistry, Biological and Medicinal Chemistry Sector ‘Lifetime Achievement Award in Medicinal Chemistry
ARE YOU INTO DMPK? CALL FOR POSTERS AND REGISTRATION NOW OPEN: 3RD NEW PERSPECTIVES IN DMPK: THE IMPACT OF DRUG DESIGN. 8TH AND 9TH FEBRUARY 2016 AT THE ROYAL SOCIETY OF CHEMISTRY, BURLINGTON HOUSE, LONDON
Closing date for poster submission is 15th January.
This meeting will provide a forum for the exchange of ideas between principal members of the DMPK research community. The agenda will include keynote talks from industry leaders, who will frame specific topic discussions with more global views of how DMPK can bring value to the process of informing drug discovery. The emphasis throughout will be on building dialogue between participants who will range from experienced project/laboratory leaders to early-career researchers, via platform presentations, Q&A, poster sessions, and associated social mixer events.
WHAT STAR©’S! 2015 MALCOM CAMPBELL MEMORIAL PRIZE AWARDED TO MILES CONGREVE, FIONA MARSHALL AND MALCOM WEIR, HEPTARES THERAPEUTICS LTD.
The prize was for the seminal contributions to GPCR drug discovery made by Heptares Therapeutics Ltd since the company was founded in 2007.
This work has included building the world-renowned StaR© technology platform for X-ray crystallography of GPCRs and the invention of a number of clinical candidates.
More information is available on http://www.rsc.org/Membership/Networking/InterestGroups/BMCS/Activities/CampbellAward.asp
SIR SIMON CAMPBELL AWARDED THE FIRST ‘RSC-BMCS LIFETIME ACHIEVEMENT AWARD’
Sir Simon Campbell was presented with the inaugural Royal Society of Chemistry, Biological and Medicinal Chemistry Sector ‘Lifetime Achievement Award in Medicinal Chemistry at the 18th RSC-SCI Medicinal Chemistry Symposium in Cambridge on Wednesday 16th September 2015 in recognition of his many contributions to the field.
Find out more on http://www.rsc.org/Membership/Networking/InterestGroups/BMCS/ (scroll to bottom of page)
Partnership agreement between Life Science Switzerland (LS2) and the Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS)
The coalition Life Sciences Switzerland (LS2) is a non-profit organisation dedicated to advancing biological sciences within the Swiss academic community and to addressing the social, ethical and economic issues raised by the rapid progress of the biomedical and life sciences. Life Science Switzerland (LS2) and the Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society (SCS) have signed an agreement to establish a collaborative relationship for the progress of Life Science, with focus on Medicinal Chemistry, Chemical Biology and related fields of research in Switzerland.
The main points of the agreement are that
- both partners will establish regular interactions to explore synergies between their societies, and inform their members about the activities of the other party.
- the DMCCB will organize a scientific session at the next LS2 annual meeting in Lausanne, while LS2 will organize a session at the SCS Fall Meeting in 2017.
- in addition, members of both societies are offered regular member registration fees at each other's event, as well as a one-off 10% discount for new dual memberships.
- finally, LS2 will guest-edit the December 2016 edition of CHIMIA, showcasing its scientific activities to the SCS members.
Both organizations are looking forward to an open and constructive collaboration aiming to develop into a strong partnership, for the benefit of life sciences, medicinal chemistry and chemical biology in Switzerland.
Prof. Gabriele Costantino is the President of the Division of Medicinal Chemistry of the Italian Chemical Society for the 2016-2018 Term
More than 600 members of the Division of Medicinal Chemistry of the Italian Chemical Society have been called to the election of the President and the Executive Committee for the 2016-2018.
The new President is Gabriele Costantino, professor of medicinal chemistry at University of Parma. The new Executive Committee is composed by Cosimo Altomare (University of Bari), Tiziano Bandiera (Italian Institute of Technology, Genova), Federico Corelli (University of Siena), Maurizio DelCanale (Chiesi Farmaceutici, Parma), Roberto Di Santo (University of Rome ‘La Sapienza), Vincenza Andrisano (University of Bologna), Gianluca Sbardella (University of Salerno) and Girolamo Cirrincione (Past President, University of Palermo). Gabriele Costantino, who has served as a Member of the Executive Committee of the EFMC (2010-2015) will be the official representative of Italy at the EFMC Council.
Frontiers in Medicinal Chemistry - Bonn, Germany - March 13-16, 2016
This symposium, jointly organised by the Deutsche Pharmazeutische Gesellschaft (GDCh-DPhG) and the Société de Chimie Thérapeutique (SCT), will focus on current developments, novel approaches and cutting-edge technologies in the field of medicinal chemistry and drug research with sessions on Target Identification & Lead Discovery, Allosteric Modulators & Modulation of Protein-Protein Interactions, Antibacterial Drugs, Structural Biology, and Highlights in Medicinal Chemistry and Technology.
The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of (post)doctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research.
Find out more:
2016 IUPAC-Richter Prize in Medicinal Chemistry
The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.
Prize USD 10 000
The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays towards improving human health.
Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional autobiography of not more than two pages, and a one-page summary of what the individual considers to be his/her activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.
For further information, please contact Professor Janos Fischer, Chariman of the IUPAC Subcommittee on Drug Discovery and Drug Development, by email at firstname.lastname@example.org
Nomination materials should be submitted by 15 February 2016 to IUPAC
Secretariat by email at: email@example.com
Telephone: +1 (919) 485 8700
Fax: +1 (919) 485 8706
ISSUE SPONSORED BY
Founded in 2001, GalChimia has become the Spanish leader in synthetic organic chemistry. Our expert, dedicated team of chemists has found a productive outlet for their obsession with chemistry, providing services to clients worldwide.
EFMC ORGANISED EVENTS
EFMC SPONSORED EVENTS
EFMC ACCREDITED SCHOOL
EFMC SPONSORED SCHOOLS
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
Find us on social media